Buyback Spend for Gilead Sciences (GILD)
Buyback Spend for Gilead Sciences (GILD): headline value $1.92B · YoY +67.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingBuyback SpendSwitch metric
Latest period
$1.92B
YoY change
+67.1%
5Y CAGR
+4.0%
Peak year (2016)
$11.00B
Latest annual
$1.92B
Buyback Spend history chart for Gilead Sciences (GILD) from 1990 to 2025
Buyback Spend history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $1.92B | +67.1% | ||
| 2024 | $1.15B | +15.0% | ||
| 2023 | $1.00B | -28.4% | ||
| 2022 | $1.40B | +155.7% | ||
| 2021 | $546.00M | -65.5% | ||
| 2020 | $1.58B | -9.5% | ||
| 2019 | $1.75B | -39.7% | ||
| 2018 | $2.90B | +204.0% | ||
| 2017 | $954.00M | -91.3% | ||
| 2016 | $11.00B | +10.0% | ||
| 2015 | $10.00B | +87.0% | ||
| 2014 | $5.35B | +819.1% | ||
| 2013 | $582.00M | -12.7% | ||
| 2012 | $667.00M | -72.0% | ||
| 2011 | $2.38B | -40.8% | ||
| 2010 | $4.02B | +302.9% | ||
| 2009 | $998.50M | -49.3% | ||
| 2008 | $1.97B | +304.0% | ||
| 2007 | $487.54M | -10.5% | ||
| 2006 | $544.94M | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — |
Buyback Spend values are taken from Gilead Sciences's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Gilead Sciences (GILD) buyback spend totalled $1.92B – surged 67.1% year-over-year.
Through 2020–2025 (5 years), Gilead Sciences buyback spend delivered a +4.0% annualised rate; sustaining 2 straight years of year-over-year growth.
Gilead Sciences buyback spend plunged from $11.00B in 2016 to $1.92B in 2025, a 82.5% drawdown.
The highest annual buyback spend of $11.00B was reported in 2016. The lowest in the available history was $0 in 1990.
Gilead Sciences (GILD) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.
Gilead Sciences Buyback Spend by Year
Gilead Sciences Buyback Spend 2025: $1.92B
Gilead Sciences buyback spend in 2025 was $1.92B, surged 67.1% from 2024.
Gilead Sciences Buyback Spend 2024: $1.15B
Gilead Sciences buyback spend in 2024 was $1.15B, grew 15.0% from 2023.
Gilead Sciences Buyback Spend 2023: $1.00B
Gilead Sciences buyback spend in 2023 was $1.00B, declined 28.4% below 2022.
Gilead Sciences Buyback Spend 2022: $1.40B
Gilead Sciences buyback spend in 2022 was $1.40B, surged 155.7% from 2021.
Gilead Sciences Buyback Spend 2021: $546.00M
Gilead Sciences buyback spend in 2021 was $546.00M.
See more financial history for Gilead Sciences (GILD).
Sector peers — Buyback Spend
Companies in the same sector as Gilead Sciences, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Gilead Sciences's buyback spend?
Latest reported buyback spend for Gilead Sciences (GILD) is $1.92B (period ending December 31, 2025).
How has Gilead Sciences buyback spend changed year-over-year?
Gilead Sciences (GILD) buyback spend changed +67.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences buyback spend?
Gilead Sciences (GILD) buyback spend compound annual growth rate is +4.0% over the most recent 5 years available.
When did Gilead Sciences buyback spend hit its highest annual value?
Gilead Sciences buyback spend reached its highest annual value of $11.00B in 2016.
What was Gilead Sciences buyback spend in 2024?
Gilead Sciences (GILD) buyback spend in 2024 was $1.15B.
What was Gilead Sciences buyback spend in 2025?
Gilead Sciences (GILD) buyback spend in 2025 was $1.92B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.